Literature DB >> 19804428

Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995-2005: an analysis of PALGA, the Dutch national histopathology registry.

Evelyne C C Cauberg1, Maartje A Salomons, Intan P E D Kümmerlin, Theo M de Reijke, Aeilko H Zwinderman, Jean J M C H de la Rosette, Fiebo J W Kate, M Pilar Laguna Pes.   

Abstract

OBJECTIVE: To evaluate changes in incidence, distribution of stage and grade as well as surgical treatment of upper urinary tract (UUT) tumours in the Netherlands from 1995 to 2005. PATIENTS AND METHODS: The PALGA registry, a nationwide network and registry of pathology encompassing all hospitals in the Netherlands, was used as primary data source. Pathology reports of all primary surgical procedures or biopsies without further surgical treatment within the next year, of cancer of the renal pelvis or ureter during the period 1995-2005, were included. The number of surgically treated UUT tumours per year, type of treatment and tumour characteristics were recorded.
RESULTS: The population consisted of 2321 (67%) men and 1145 (33%) women with a mean age of 68.6 years. The distribution according to side was similar (left 44.1%, right 41.5%), bilateral tumours were rare (0.6%) and most tumours were in the renal pelvis (51.3%). Both the incidence and the incidence rate per 100 000 person-years increased during the study period (P < 0.001). Most urothelial cancers were grade 2 (40.9%) or 3 (41.2%) and stage Ta (30.6%), T1 (18.1%) or T3 (22.8%). There was an increase in grade 3 (P = 0.003) and muscle-invasive (P = 0.003) tumours in men only. Nephroureterectomy was performed in 41.3% of the cases and there was an increasing trend to endoscopic surgery (P = 0.019), although the absolute number was low.
CONCLUSION: The incidence of surgically treated UUT tumours increased, with a significant trend towards more advanced disease in men. Most tumours were treated by nephroureterectomy or nephrectomy, although there was an increasing trend to endoscopic surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19804428     DOI: 10.1111/j.1464-410X.2009.08889.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

1.  Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?

Authors:  Mesut Remzi; Shahrokh Shariat; Wilhelm Huebner; Harun Fajkovic; Christian Seitz
Journal:  Ther Adv Urol       Date:  2011-04

Review 2.  The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tract.

Authors:  Tsunenori Kondo; Kazunari Tanabe
Journal:  Int J Clin Oncol       Date:  2011-04-21       Impact factor: 3.402

3.  The incidence and prevalence of upper tract urothelial carcinoma: a systematic review.

Authors:  Ahmed Soualhi; Elke Rammant; Gincy George; Beth Russell; Deborah Enting; Rajesh Nair; Mieke Van Hemelrijck; Cecilia Bosco
Journal:  BMC Urol       Date:  2021-08-17       Impact factor: 2.264

4.  Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010).

Authors:  Ming-Yen Lin; Sheng-Wen Niu; Wei-Ming Li; Huei-Lan Lee; Li-Tzong Chen; Wen-Jeng Wu; Shang-Jyh Hwang
Journal:  Int J Urol       Date:  2021-10-27       Impact factor: 2.896

5.  Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study.

Authors:  Bjarte Almås; Ole J Halvorsen; Tom Børge Johannesen; Christian Beisland
Journal:  World J Urol       Date:  2021-01-09       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.